BackUroGen Pharma Overview

UroGen Pharma Cost of Revenue

Cost of Revenue analysis for URGN.

Quarterly Cost of Revenue

$4.14M
↑ 77.64% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$14.26M
↑ 50.33% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin